title: Formulation of ternary complexes of glyburide with hydroxypropyl-β-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds.
abstract: Glyburide, a sulfonylurea derivative, widely used as hypoglycaemic agent. In the present study, an attempt has been made to investigate the most effective third component which can be used with hydroxylpropyl-β-cyclodextrin (HPβCd) to form a ternary complex with glyburide in order to enhance its dissolution rate, as well as reduce the amount of HPβCd used for formulating the binary complex with glyburide. Moreover, the objective of this study was also to develop a discriminatory dissolution media in order to discriminate the effect of the different solubilizing agents used for formulating the ternary complex system. Sodium lauryl sulphate, Poloxamer-188, Polyvinylpyrrolidone K-30, lactose and L-arginine were used to formulate ternary system along with HPβCd and glyburide. The ternary system formulated with glyburide:HPβCd:L-arginine in a proportion of 1:1:0.5 has shown the fastest dissolution rate when compared to other solubilizing agents. Unbuffered aqueous media with stirring speed 50 rpm has produced the most discriminatory dissolution profiles. The DSC thermograms and the powder X-ray analysis revealed the decrease in crystallinity of the drug. This was an indication of amorphous solid dispersion or molecular encapsulation of the drug into the cyclodextrin cavity.
authors.affiliation: Department of Pharmacy, Karpagam University, Coimbatore, Tamilnadu, India. sachin_pharma06@yahoo.co.in
authors.forename: Sachin Kumar
authors.initials: SK
authors.lastname: Singh
authors.forename: K K
authors.initials: KK
authors.lastname: Srinivasan
authors.forename: Dhananjay S
authors.initials: DS
authors.lastname: Singare
authors.forename: K
authors.initials: K
authors.lastname: Gowthamarajan
authors.forename: Dev
authors.initials: D
authors.lastname: Prakash
mesh_terms: D000073738:2-Hydroxypropyl-beta-cyclodextrin; D002021:Buffers; D002152:Calorimetry, Differential Scanning; D004339:Drug Compounding; D005905:Glyburide / Q000008:administration & dosage / Q000737:chemistry*; D006863:Hydrogen-Ion Concentration; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000737:chemistry*; D007700:Kinetics; D010592:Pharmaceutic Aids / Q000737:chemistry*; D044367:Phase Transition; D012995:Solubility; D013314:Stress, Mechanical; D013607:Tablets; D013997:Time Factors; D014867:Water / Q000737:chemistry; D014961:X-Ray Diffraction; D047392:beta-Cyclodextrins / Q000737:chemistry*
chemical_list: D002021:Buffers; D007004:Hypoglycemic Agents; D010592:Pharmaceutic Aids; D013607:Tablets; D047392:beta-Cyclodextrins; D014867:Water; D000073738:2-Hydroxypropyl-beta-cyclodextrin; D005905:Glyburide